Antifibrinolytic activity during administration of epsilon-aminocaproic acid.
D000284:Administration, Oral; D000614:Aminocaproates / Q000008:administration & dosage / Q000627:therapeutic use*; D003864:Depression, Chemical; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D002532:Intracranial Aneurysm / Q000150:complications / Q000201:enzymology; D012422:Rupture, Spontaneous / Q000150:complications; D013300:Streptokinase; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D000614:Aminocaproates; D013300:Streptokinase